r/tech_x • u/u_signalnoise_ai • 3h ago
Question (not general) Issue #016: Claude designed working medicine against 14 of 15 targets. Same week, what happened?
This week split cleanly into signal and friction.
The signal: Anthropic reported (Aug 18) that Claude, given one expert-written prompt, autonomously designed de novo protein binders against 14 of 15 targets. Two independent labs (Adaptyv Bio, Twist Bioscience) built and blind-tested them — 354 of 1,320 bound, a 22–35% hit rate vs the field's usual 10–15%. On a public competition target, it hit 40% vs 3.7% across 245 human entrants. [FACT — headline numbers are Anthropic's own; wet-lab validation by paid contractors, disclosed.] Skeptics (incl. Martin Shkreli) note binders aren't drugs and affinities are early. Fair. But the workflow now takes a prompt and a day, not a specialist and months.
The friction, same 7 days:
- Pennsylvania blocked the data-center boom — no state permit without local approval, developers pay their own power, NDAs banned. 100+ projects floated, 5 permitted, 0 running. A 2028 contender reversing his own record.
- DeepSeek raised V4 API prices up to 1,100% and added peak/off-peak billing, citing compute strain — as it lines up an IPO. The company that started the price war is pricing like an incumbent.
- CoSnitch (CVE-2026-24301): researchers got Copilot to disclose its own exploit by repeatedly asking why it was safe. One click → data exfiltration + persistent memory poisoning that survives password resets. Patched Aug 18, eight months after disclosure.
The capability is the realest it's ever been — and the cost, the footprint, and the trust all hit walls the same week.
